PMVP

PMV Pharmaceuticals, Inc

1.04

USD

PMVP Earnings Reports

Positive Surprise Ratio

PMVP beat 12 of 20 last estimates.

60%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.41

Implied change from Q3 25 (Revenue/ EPS)

+2.50%

Implied change from Q4 24 (Revenue/ EPS)

-8.89%

PMV Pharmaceuticals, Inc earnings per share and revenue

On Nov 12, 2025, PMVP reported earnings of -0.40 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 2.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.77% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.41 USD, with revenue projected to reach -- USD, implying an increase of 2.50% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were PMV Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, PMV Pharmaceuticals, Inc reported EPS of -$0.40, beating estimates by 2.58%, and revenue of $0.00, 0% as expectations.

How did the market react to PMV Pharmaceuticals, Inc's Q3 2025 earnings?

The stock price moved up 6.77%, changed from $1.33 before the earnings release to $1.42 the day after.

When is PMV Pharmaceuticals, Inc expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for PMV Pharmaceuticals, Inc's next earnings report?

Based on 6 analysts, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.41 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.